Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification. (65/134)

 (+info)

Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3beta and mitochondrial function. (66/134)

 (+info)

CD36 as a target to prevent cardiac lipotoxicity and insulin resistance. (67/134)

 (+info)

Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels. (68/134)

 (+info)

Diabetic cardiomyopathy: myth or reality? (69/134)

 (+info)

Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. (70/134)

 (+info)

Cardioprotective effect of sodium ferulate in diabetic rats. (71/134)

 (+info)

Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart. (72/134)

 (+info)